Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and Influenza – Tender Specifications OJ/2021/DPR/12924  DL 3.3.3. Support  implementation of the  vaccine effectiveness  study(s)  Support countries by providing methodological and technical support to  implementation of the vaccine effectiveness study.  A report of activities, including a list of frequently asked questions and their  answers.  Once a year  Word  DL 3.3.4. Datasets of  data collected in the  vaccine effectiveness  study and regular  summary report  Collection (as needed) and validation of dataset. The final formats shall be agreed during the monthly conference calls with ECDC. Deliverable includes scripts, validated datasets/databases and short summary  report. The summary table shall include the number of events (primary and  secondary events defined in the study protocol), number of vaccinations performed  (including information on brand, number of first and second doses, as defined in the  study protocol). Cumulative data presented since the beginning of data collection  showing total and per country specifications. Dataset/database to be delivered  compatible with a TESSy format, including validated data since the beginning of data  collection. The validation of the datasets will be performed in close collaboration with the  countries and will be aimed to build capacity and foster a progressive improvement  of data reported by the countries/long-term care facilities over the course of the  project. Communication between the contractor and the countries to validate the  data will take place using principles agreed between the contractor and ECDC and  periodically revisited.  Every 4 months,  starting after data  collection  Word and format  compatible with  statistical software  (e.g. STATA, R, csv)  DL 3.3.5. Regular  laboratory results  summary table.  The contractor shall provide a quarterly laboratory results summary table to ECDC  specifying the number of laboratory specimens processed and tested and the  proportion of positive samples by study site. This deliverable includes all costs of  sample processing, transport, laboratory data management and the diagnostic assay  and refers to cost of performing the molecular diagnostic (i.e. RT-PCR) and serology,  including standardization. Every 4 months,  starting after data  collection  Word  Excel or other  statistical software 